Skip to main content
CVS HEALTH Corp logo

CVS HEALTH Corp — Investor Relations & Filings

Ticker · CVS ISIN · US1266501006 LEI · 549300EJG376EN5NQE29 US Human health and social work activities
Open in API
Filings indexed 2,766 across all filing types
Latest filing 2024-02-13 Major Shareholding Noti…
Country US United States of America
Listing US CVS

About CVS HEALTH Corp

https://cvshealth.com/

CVS Health Corporation is a diversified health solutions company that provides integrated healthcare services. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers a broad range of health insurance products and related services. The Health Services segment provides comprehensive pharmacy benefit management (PBM) solutions, specialty pharmacy services for complex conditions, and accessible clinical care through its network of retail health clinics and primary care centers. The Pharmacy & Consumer Wellness segment consists of its retail pharmacy chain, which dispenses prescription medications and sells a wide variety of over-the-counter health products, personal care items, and general merchandise. The company focuses on simplifying the healthcare experience and improving health outcomes by making care more accessible, affordable, and personalized.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G/A
Major Shareholding Notification
2024-02-13 English
Regulatory Filings 2024
Regulatory Filings
2024-02-09 English
10-K
Annual Report FY 2023
2024-02-07 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 7, 2024, reporting the results of operations and financial condition for CVS Health Corporation for the three months and full year ended December 31, 2023. It specifically states that a press release announcing these results is furnished as an exhibit. The document itself is a current report announcing the earnings results, not the full earnings report or detailed financial statements. The length is 3704 characters, which is relatively short and consistent with an earnings release announcement rather than a full report. Therefore, this document fits the category of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only.
2024-02-07 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-01-26 English
CURRENT REPORT
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by CVS Health Corporation. It includes Item 2.02 which provides updates on results of operations and financial condition, including reaffirmation of earnings guidance and financial metrics. It also includes Item 5.02 and 7.01 which announce changes in senior management, specifically the appointment and departure of key executives. The document contains detailed financial guidance and management changes but does not present a full annual or quarterly report with comprehensive financial statements. It is not a transcript, proxy, or legal proceeding report. The presence of management appointments and departures points to Board/Management Information. The financial guidance and operational updates in Item 2.02 are typical for an 8-K but do not constitute a full earnings release or interim report. Therefore, the primary classification is Board/Management Information (MANG) due to the significant management changes announced, with a secondary note on financial updates typical of 8-K filings. Confidence is high given the clear presence of management changes and the nature of the filing.
2024-01-05 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.